Download PDF
Thromb Haemost 2006; 96(02): 176-182
DOI: 10.1160/TH06-05-0270
Platelets and Blood Cells
Schattauer GmbH

Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A

Flóra Kiss   *
1   Department of Clinical Biochemistry and Molecular Pathology
,
Zsuzsanna Hevessy   *
1   Department of Clinical Biochemistry and Molecular Pathology
,
Anikó Veszprémi
1   Department of Clinical Biochemistry and Molecular Pathology
,
Éva Katona
2   Clinical Research Center, Thrombosis and Haemostasis Research Group of the Hungarian Academy of Sciences
,
Csongor Kiss
3   Department of Pediatrics
,
György Vereb
4   Department of Biophysics and Cell Biology, Medical and Health Science Center; University of Debrecen, Debrecen, Hungary
,
László Muszbek
2   Clinical Research Center, Thrombosis and Haemostasis Research Group of the Hungarian Academy of Sciences
,
János Kappelmayer
1   Department of Clinical Biochemistry and Molecular Pathology
› Author AffiliationsFinancial support: This work was supported by grants from the University of Debrecen Medical and Health Science Center (Mec 13–2002), the Hungarian National Fund OTKA (T049392 and T043086) and the Hungarian Ministry of Health (ETT 355/2003).
Further Information

Publication History

Received 16 May 2006

Accepted after resubmission 07 July 2006

Publication Date:
28 November 2017 (online)

Also available at
    Permissions and Reprints

Summary

Blood coagulation factor XIII (FXIII) is a protransglutaminase circulating asa tetramer formed by two types of subunits (A2B2). The intracellular dimeric form of FXIII (A2) is present in platelets, megakaryocytes, monocytes and macrophages and has been detected in mono-and megakaryocytic leukemias. The aim of our study was to investigate FXIII-A expression in newly diagnosed B cell acute lymphoblastic leukemia (ALL) samples. We examined 47 de novo ALL cases of B cell origin by triple color labeling with flow cytometry. FXIII-A was detected by a FITC conjugated monoclonal antibody combined with CD34 and CD45 staining. In selected cases FXIII-A was investigated on slides prepared from blasts and visualized with a fluorescent microscope. In addition, blasts were studied by Western blot analysis and FXIII-A was measured by a highly sensitive ELISA method. By flow cytometry 19 samples of the 47 cases were found to be FXIII-A positive. Antigen concentration was 3.11± 1.19 fg/blast, while normal lymphoid precursors and mature lymphocytes from B-CLL did not contain FXIII-A. In the lysate of lymphoblasts that were positive by flow cytometry, a single band (82 kDa) corresponding to FXIII-A was detected on Western blots. Confocal laser scanning microscopic examination revealed the presence of FXIII-A in the cytoplasm of these lymphoblasts. This novel expression site of FXIII-A in leukemic lymphoblasts can be utilized as a diagnostic tool and may also gain functional significance in B-lineage ALL.

Keywords

Coagulation factor XIII - acute lymphoblastic leukemia - flow cytometry

* These authors contributed equally.


 

  • References

  • 1 Muszbek L, Ádány R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 1996; 33: 357-421.
    CrossrefPubMedGoogle Scholar
  • 2 Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999; 94: 271-305.
    CrossrefPubMedGoogle Scholar
  • 3 Muszbek L, Ádány R, Szegedi G. et al. Factor XIII of blood coagulation in human monocytes. Thromb Res 1985; 37: 401-10.
    CrossrefPubMedGoogle Scholar
  • 4 Henriksson P, Becker S, Lynch G. et al. Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 1985; 76: 528-34.
    CrossrefPubMedGoogle Scholar
  • 5 Ádány R, Belkin A, Vasilevskaya T. et al. Identification of blood coagulation factor XIII in human peritoneal macrophages. Eur J Cell Biol 1985; 38: 171-3.
    PubMedGoogle Scholar
  • 6 Kiesselbach TH, Wagner RH. Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique. Ann NY Acad Sci 1972; 202: 318-28.
    CrossrefPubMedGoogle Scholar
  • 7 Buluk K. An unknown function of blood platelets. Polski Tygod Lekar 1955; 10: 191-7.
    PubMedGoogle Scholar
  • 8 Ádány R, Kiss A, Muszbek L. Factor XIII: a marker of mono-and megakaryocytopoiesis. Br J Haematol 1987; 67: 167-72.
    CrossrefPubMedGoogle Scholar
  • 9 Kappelmayer J, Bacskó G, Birinyi L. et al. Consecutive appearance of coagulation factor XIII subunit A in macrophages, megakaryocytes and liver cells during early phase of human development. Blood 1995; 86: 2191-7.
    PubMedGoogle Scholar
  • 10 Kappelmayer J, Simon A, Katona E. et al. Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias. Thromb Haemost 2005; 94: 454-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Drexler HG, Thiel E, Ludwig WD. Review of the incidence and clinical relevance of myeloid antigenpositive acute lymphoblastic leukemia. Leukemia 1991; 05: 637-45.
    PubMedGoogle Scholar
  • 12 Preti HA, Huh YO, O’Brien SM. et al. Myeloid markers in adult acute lymphoblastic leukemia. Correlations with patient and disease characteristics and with prognosis. Cancer 1995; 76: 1564-70.
    CrossrefPubMedGoogle Scholar
  • 13 Lauria F, Raspadori D, Martinelli G. et al. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukemia patients: diagnostic and prognostic implications. Br J Haematol 1994; 87: 286-92.
    CrossrefPubMedGoogle Scholar
  • 14 Boldt DH, Kopecky KJ, Head D. et al. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group Experience. Leukemia 1994; 08: 2118-26.
    PubMedGoogle Scholar
  • 15 Orfao A, Ciudad J, López-Berges MC. et al. Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry. Leuk Lymphoma 1994; 13 (Suppl. 01) 87-90.
    CrossrefPubMedGoogle Scholar
  • 16 Lucio P, Gaipa G, van Lochem EG. et al. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 concerted action investigation of minimal residual disease in acute leukemia: international standardization and clinical evaluation. Leukemia 2001; 15: 1185-92.
    CrossrefPubMedGoogle Scholar
  • 17 McKenna RW, Washington LT, Aquino DB. et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 2001; 98: 2498-507.
    CrossrefPubMedGoogle Scholar
  • 18 Katona E, Ajzner E, Tóth K. et al. Enzyme linked immunosorbent assay (ELISA) for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J Immunol Methods 2001; 258: 127-35.
    CrossrefPubMedGoogle Scholar
  • 19 Bene MC, Castoldi G, Knapp W. et al. „Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)”. Leukemia 1995; 09: 1783-6.
    PubMedGoogle Scholar
  • 20 Buccheri V, Matutes E, Dyer MJS. et al. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993; 07: 919-27.
    PubMedGoogle Scholar
  • 21 Deptala A, Halicka HD, Salomon T. et al. Malignancy: A New Approach to the Analysis of Apoptosis in the Leukemic Subpopulation by Flow Cytometry Using a CD45 Gating Strategy. Hematology 1999; 04: 113-21.
    CrossrefPubMedGoogle Scholar
  • 22 Lacombe F, Durrieu F, Briais A. et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 1997; 11: 1878-86.
    CrossrefPubMedGoogle Scholar
  • 23 Kappelmayer J, Gratama JW, Karaszi E. et al. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interactions between monoclonal antibody clones, fluorochromes and sample preparation protocols. J Immunol Methods 2000; 242: 53-65.
    CrossrefPubMedGoogle Scholar
  • 24 Invernizzi R, De Fazio P, Iannone AM. et al. Immunocytochemical detection of factor XIII A-subunit in acute leukemia. Leuk Res 1992; 16: 829-36.
    CrossrefPubMedGoogle Scholar
  • 25 Campana D, Coustand-Smith E. Minimal residual disease studies by flow cytometry in acute leukemia. Acta Haematol 2004; 112: 8-15.
    CrossrefPubMedGoogle Scholar
  • 26 Garcia JAVela, Monteserin MC, Delgado I. et al. Aberrant immunophenotypes detected by flow cytometry in acute lymphoblastic leukemia. Leuk Lymphoma 2000; 36: 275-84.
    CrossrefPubMedGoogle Scholar
  • 27 Ádány R, Bárdos H, Antal M. et al. Factor XIII of blood coagulation as a nuclear crosslinking enzyme. Thromb Haemost 2001; 85: 845-51.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Sárváry A, Szûcs S, Balogh I. et al. Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis. Cell Immunol 2004; 228: 81-90.
    CrossrefPubMedGoogle Scholar
  • 29 Törôcsik D, Bárdos H, Nagy L. et al. Identification of factor XIII-A as a marker of alternative macrophage activation. Cell Mol Life Sci 2005; 62: 2132-9.
    CrossrefPubMedGoogle Scholar
  • 30 Dardik R, Loscalzo J, Eskaraev R. et al. Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler Thromb Vasc Biol 2005; 25: 526-32.
    CrossrefPubMedGoogle Scholar